Addition of deoxynucleosides enhances human immunodeficiency virus type 1 integration and 2LTR formation in resting CD4+ T cells.
Addition of deoxynucleosides enhances human immunodeficiency virus type 1 integration and 2LTR formation in resting CD4+ T cells. Research Abstract Details
Resting CD4(+) T cells restrict human immunodeficiency virus (HIV) infection at a step prior to integration. Despite this restriction, we showed previously that HIV integration occurs in resting CD4(+) T cells in vitro, albeit at lower levels than in activated CD4(+) T cells. Here we show that addition of deoxynucleosides enhanced integration and 2LTR formation in resting CD4(+) T cells but that the kinetics were still significantly delayed compared to those of activated T cells. Thus, deoxynucleoside addition partially overcomes the restriction to HIV infection in resting CD4(+) T cells.
Addition of deoxynucleosides enhances human immunodeficiency virus type 1 integration and 2LTR formation in resting CD4+ T cells. Publishing Authors By Initials
Addition of deoxynucleosides enhances human immunodeficiency virus type 1 integration and 2LTR formation in resting CD4+ T cells. Journal Published:
PUBLICATION TYPE: Research Support, Non-U.S. Gov
Journal: Journal of virology
VOLUME: 81
Page Numbers: 13938-42
Journal Abbreviation: J. Virol.
ISSN: 1098-5514
DAY: 10
MONTH: 10
YEAR: 2007
Addition of deoxynucleosides enhances human immunodeficiency virus type 1 integration and 2LTR formation in resting CD4+ T cells. Information
Number of References:
LANGUAGE: eng
NlmUniqueID: 113724
Addition of deoxynucleosides enhances human immunodeficiency virus type 1 integration and 2LTR formation in resting CD4+ T cells. Keywords Mesh Terms:
KEYWORDS:
MESH TERMS:
Chemical & Substance for Abstract: Addition of deoxynucleosides enhances human immunodeficiency virus type 1 integration and 2LTR formation in resting CD4+ T cells. Information
Substance Name:
Registry Number:
Grant and Affiliation Information for Addition of deoxynucleosides enhances human immunodeficiency virus type 1 integration and 2LTR formation in resting CD4+ T cells.
AFFILIATION: Department of Pathology and Laboratory Medicine, Division of Transfusion Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA.
Country: United States
AGENCY: United States NIAID
GRANT: R21AI64031-A1
ACRONYM: AI
MEDLINETA: J Virol
REFSOURCE:
DATABASENAME:
ACCESSION NUMBER:
Number Hits: 0
Addition of deoxynucleosides enhances human immunodeficiency virus type 1 integration and 2LTR formation in resting CD4+ T cells Related Publications